code of conduct
  0. Preamble
  1. The Code Explained
  2. Duty of Care
  2.1 Good Clinical Practice
  2.2 Medical Integrity
  3. Competence and Diligence
  3.1 General issues in clinical research
  3.2 Studies of human pharmacology
  3.3 Studies of therapeutic use and post-marketing surveillance
  3.4 Special and vulnerable patient groups
  3.5 Benefit - risk assessments
  3.6 Awareness of innovation
  4. Impartiality
  4.1 Promotion
  4.2 Provision of information
  4.3 Information to healthcare professionals
  4.4 Information to patients
  4.5 Information to the media
  5. Probity
  5.1 Accurate reporting
  5.2 Research accountability
  5.3 Financial and commercial dealings
  6. Integrity and Accountability in the Workplace
  6.1 Propriety
  6.2 Teamwork
  6.3 Leadership

Addenda:
International Code of Ethical Conduct for Pharmaceutical Physicians   
Poster Cancun ICPM 2002 - Dr Sander Becker   
about IFAPP news members join us education ethics conferences links sponsors